| Apogee Therapeutics, Inc. | 40,796 | US$5.47M | 1.1% |
| Oruka Therapeutics, Inc. | 52,700 | US$5.09M | 1.0% |
| Dianthus Therapeutics, Inc. | 44,156 | US$4.72M | 0.96% |
| Erasca, Inc. | 252K | US$4.58M | 0.93% |
| Twist Bioscience Corporation | 49,791 | US$4.56M | 0.92% |
| Kymera Therapeutics, Inc. | 43,133 | US$4.46M | 0.90% |
| Spyre Therapeutics, Inc. | 44,942 | US$4.42M | 0.89% |
| Revolution Medicines, Inc. | 23,402 | US$4.39M | 0.89% |
| Cg Oncology, Inc. | 61,441 | US$4.37M | 0.88% |
| Protagonist Therapeutics, Inc. | 31,902 | US$4.36M | 0.88% |
| Praxis Precision Medicines, Inc. | 14,020 | US$4.32M | 0.87% |
| Regeneron Pharmaceuticals, Inc. | 5,608 | US$4.28M | 0.87% |
| Cogent Biosciences, Inc. | 108K | US$4.19M | 0.85% |
| Natera, Inc. | 15,588 | US$4.17M | 0.84% |
| Arrowhead Pharmaceuticals, Inc. | 47,707 | US$4.04M | 0.82% |
| Travere Therapeutics, Inc. | 72,196 | US$4.04M | 0.82% |
| Roivant Sciences Ltd. | 119K | US$4.03M | 0.81% |
| Relay Therapeutics, Inc. | 214K | US$4.02M | 0.81% |
| Moderna, Inc. | 73,372 | US$4.02M | 0.81% |
| Vaxcyte, Inc. | 74,294 | US$4.02M | 0.81% |
| Bridgebio Pharma, Inc. | 50,063 | US$4.01M | 0.81% |
| Halozyme Therapeutics, Inc. | 47,863 | US$3.95M | 0.80% |
| Rhythm Pharmaceuticals, Inc. | 39,370 | US$3.91M | 0.79% |
| Cytokinetics, Incorporated | 50,312 | US$3.88M | 0.78% |
| Viking Therapeutics, Inc. | 122K | US$3.86M | 0.78% |
| Amgen Inc. | 9,994 | US$3.85M | 0.78% |
| Incyte Corporation | 32,018 | US$3.83M | 0.77% |
| Mirum Pharmaceuticals, Inc. | 35,899 | US$3.8M | 0.77% |
| Alkermes Plc | 76,970 | US$3.77M | 0.76% |
| Tg Therapeutics, Inc. | 72,380 | US$3.77M | 0.76% |
| Abbvie Inc. | 15,001 | US$3.76M | 0.76% |
| Vertex Pharmaceuticals Incorporated | 7,744 | US$3.69M | 0.75% |
| Krystal Biotech, Inc. | 10,801 | US$3.68M | 0.75% |
| Insmed Incorporated | 36,726 | US$3.62M | 0.73% |
| Scholar Rock Holding Corporation | 76,534 | US$3.62M | 0.73% |
| Gilead Sciences, Inc. | 27,780 | US$3.62M | 0.73% |
| Biomarin Pharmaceutical Inc. | 60,076 | US$3.61M | 0.73% |
| Uniqure N.v. | 81,217 | US$3.54M | 0.72% |
| Dyne Therapeutics, Inc. | 141K | US$3.54M | 0.72% |
| Biogen Inc. | 17,370 | US$3.53M | 0.71% |
| Neurocrine Biosciences, Inc. | 20,978 | US$3.5M | 0.71% |
| Acadia Pharmaceuticals Inc. | 135K | US$3.49M | 0.71% |
| Exelixis, Inc. | 64,176 | US$3.4M | 0.69% |
| Immunovant, Inc. | 87,318 | US$3.37M | 0.68% |
| Madrigal Pharmaceuticals, Inc. | 7,159 | US$3.35M | 0.68% |
| Grail, Inc. | 48,308 | US$3.31M | 0.67% |
| Celcuity Inc. | 38,241 | US$3.3M | 0.67% |
| Summit Therapeutics Inc. | 253K | US$3.29M | 0.67% |
| Crispr Therapeutics Ag | 68,253 | US$3.28M | 0.66% |
| United Therapeutics Corporation | 6,202 | US$3.21M | 0.65% |
| Ptc Therapeutics, Inc. | 46,006 | US$3.13M | 0.63% |
| Ultragenyx Pharmaceutical Inc. | 124K | US$3.1M | 0.63% |
| Immunitybio, Inc. | 423K | US$3.04M | 0.61% |
| Sellas Life Sciences Group, Inc. | 293K | US$2.94M | 0.59% |
| Beam Therapeutics Inc. | 114K | US$2.92M | 0.59% |
| Biocryst Pharmaceuticals, Inc. | 325K | US$2.92M | 0.59% |
| Vera Therapeutics, Inc. | 89,811 | US$2.88M | 0.58% |
| Ideaya Biosciences, Inc. | 78,418 | US$2.78M | 0.56% |
| Denali Therapeutics Inc. | 118K | US$2.71M | 0.55% |
| Tango Therapeutics, Inc. | 97,971 | US$2.66M | 0.54% |
| Arcutis Biotherapeutics, Inc. | 98,745 | US$2.65M | 0.54% |
| Celldex Therapeutics, Inc. | 68,644 | US$2.61M | 0.53% |
| Viridian Therapeutics, Inc. | 133K | US$2.52M | 0.51% |
| Disc Medicine, Inc. | 32,477 | US$2.5M | 0.51% |
| Arcus Biosciences, Inc. | 87,676 | US$2.47M | 0.50% |
| Mineralys Therapeutics, Inc. | 95,578 | US$2.44M | 0.49% |
| Ionis Pharmaceuticals, Inc. | 46,023 | US$2.38M | 0.48% |
| Alnylam Pharmaceuticals, Inc. | 11,586 | US$2.38M | 0.48% |
| Veracyte, Inc. | 50,707 | US$2.35M | 0.48% |
| Immunome, Inc. | 102K | US$2.31M | 0.47% |
| Syndax Pharmaceuticals, Inc. | 120K | US$2.28M | 0.46% |
| Recursion Pharmaceuticals, Inc. | 750K | US$2.25M | 0.46% |
| Sarepta Therapeutics, Inc. | 151K | US$2.25M | 0.45% |
| Adma Biologics Inc | 264K | US$2.23M | 0.45% |
| Kodiak Sciences Inc | 50,808 | US$2.11M | 0.43% |
| Intellia Therapeutics, Inc. | 195K | US$2.08M | 0.42% |
| Agios Pharmaceuticals, Inc. | 67,945 | US$2.04M | 0.41% |
| Iovance Biotherapeutics, Inc. | 492K | US$2M | 0.41% |
| Nurix Therapeutics, Inc. | 83,566 | US$1.94M | 0.39% |
| Palvella Therapeutics, Inc. | 13,887 | US$1.93M | 0.39% |
| Novavax, Inc. | 255K | US$1.87M | 0.38% |
| Vericel Corporation | 40,581 | US$1.87M | 0.38% |
| Biohaven Ltd. | 129K | US$1.74M | 0.35% |
| Caredx, Inc. | 38,851 | US$1.7M | 0.34% |
| Stoke Therapeutics, Inc. | 53,472 | US$1.54M | 0.31% |
| Precigen, Inc. | 241K | US$1.51M | 0.31% |
| Tyra Biosciences, Inc. | 47,312 | US$1.51M | 0.31% |
| Vir Biotechnology, Inc. | 168K | US$1.46M | 0.29% |
| Zenas Biopharma, Inc. | 45,855 | US$1.44M | 0.29% |
| Anaptysbio, Inc. | 26,728 | US$1.43M | 0.29% |
| First Tracks Biotherapeutics, Inc. | 31,615 | US$1.39M | 0.28% |
| Absci Corporation | 176K | US$1.37M | 0.28% |
| Hyperliquid Strategies Inc | 215K | US$1.34M | 0.27% |
| Cullinan Therapeutics, Inc. | 80,791 | US$1.33M | 0.27% |
| Xencor, Inc. | 65,912 | US$1.33M | 0.27% |
| Corvus Pharmaceuticals, Inc. | 99,617 | US$1.32M | 0.27% |
| Vor Biopharma Inc. | 59,675 | US$1.26M | 0.26% |
| Avalo Therapeutics, Inc. | 68,958 | US$1.26M | 0.25% |
| Ardelyx, Inc. | 252K | US$1.25M | 0.25% |
| Oric Pharmaceuticals, Inc. | 111K | US$1.23M | 0.25% |